GENFIT to Participate in Upcoming Investor Conferences

On January 5, 2023 GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs, reported that management will participate in upcoming investor conferences (Press release, Genfit, JAN 5, 2023, https://ir.genfit.com/news-releases/news-release-details/genfit-participate-upcoming-investor-conferences [SID1234625895]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details (non-exhaustive list):

Corporate Access Events during the 41st JPMorgan Healthcare Conference
Date: January 8 – 12, 2023
Location: San Francisco

Biotech Showcase: the investor conference for innovators
Date: January 9 – 11, 2023
Location: San Francisco

26thODDO BHF Forum
Date: January 9 – 10, 2023
Location: Virtual

Invest Securities Biomed Forum
Date: January 24, 2023
Location: Paris

Degroof Petercam’s Virtual Healthcare Conference
Date: January 25, 2023
Location: Virtual

SVB Securities Global Biopharma Conference
Date: February 13 – 16, 2023
Location: Virtual
Format: Fireside chat

The SVB Securities Global Biopharma Conference Fireside Chat presentation replay will be accessible through the "Events and Presentations" page of the Investor Relations section of the company’s website at https://ir.genfit.com/.

Kempen Lifesciences Conference
Date: April 25 – 26, 2022
Location: Amsterdam

In December, GENFIT held two Pipeline Day events in Paris and in New-York to present their new R&D programs and development plans. A replay of the events is available through the "Events and Presentations" page of the Investor Relations section of the company’s website at https://ir.genfit.com/.